Case Study

Leading the digital transformation at Novartis: The role of the CDO (A)

10 pages
August 2020
Reference: IMD-7-2104

In 2018, Novartis set the ambition to become a leading medicines company powered by data and digital technologies. To realize this goal, the newly appointed Chief Executive Officer (CEO), Vasant Narasimhan, set Data and Digital Leadership as one of Novartis’ five strategic priorities. As part of the new digital strategy, Bertrand Bodson, known for turning Argos from a traditional catalogue retailer to one of the third largest online retailers in the UK, was hired as its new Chief Digital Officer (CDO). Bodson arrived on the pharmaceuticals scene in the midst of exciting but also challenging times: science, technology and data were converging, progressing by leap and bounds and presenting new breakthrough opportunities. At the same time, the pharmaceutical industry was evolving, and both competitors and other players in the ecosystem were getting more sophisticated. Bodson needed to act quickly. Pharma was being disrupted and he needed to align the organization and capture the new opportunities. How could he get Novartis digitally ready?

Learning Objective
  • Explore the role and qualities of a CDO.
  • Examine what a digital transformation could entail in a multinational corporation
  • Analyze factors for successes and failures in digital transformations
Keywords
Digital Transformation, Culture Change, Chief Digital Officer
Settings
Switzerland
Novartis, Healthcare, Pharmaceuticals
2018-2019
Type
Field Research
Copyright
© 2020
Available Languages
English
Case clearing houses
Contact

Research Information & Knowledge Hub for additional information on IMD publications

This case study is part of a series
  • Leading the digital transformation at Novartis: The role of the CDO (A)
  • Leading the digital transformation at Novartis: The role of the CDO (B)
  • Leading the digital transformation at Novartis: The role of the CDO (C)
This case study is part of a series
  • Leading the digital transformation at Novartis: The role of the CDO (A)
  • Leading the digital transformation at Novartis: The role of the CDO (B)
  • Leading the digital transformation at Novartis: The role of the CDO (C)
Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics
Leading the digital transformation at Novartis: The role of the CDO (A)
By Jennifer Jordan and Shih-Han Huang
Case reference: IMD-7-2104 ©2020
Summary
In 2018, Novartis set the ambition to become a leading medicines company powered by data and digital technologies. To realize this goal, the newly ...
Reference IMD-7-2104
Copyright ©2020
Copyright owner IMD Copyright
Organization Novartis
Industry Healthcare, Pharmaceuticals
Available Languages English
Contact

Research Information & Knowledge Hub for additional information on IMD publications

Leading the digital transformation at Novartis: The role of the CDO (B)
By Jennifer Jordan and Shih-Han Huang
Case reference: IMD-7-2105 ©2020
Summary
As CDO, Bertrand Bodson needed to get Novartis digitally ready so that it could realize its goal of becoming a leading medicines company powered by...
Reference IMD-7-2105
Copyright ©2020
Copyright owner IMD Copyright
Organization Novartis
Industry Healthcare, Pharmaceuticals
Available Languages English
Contact

Research Information & Knowledge Hub for additional information on IMD publications

Leading the digital transformation at Novartis: The role of the CDO (C)
By Jennifer Jordan and Shih-Han Huang
Case reference: IMD-7-2106 ©2020
Summary
This final case in a three-part case series follows the progress, challenges and achievements of Bertrand Bodson and his digital team one year into...
Reference IMD-7-2106
Copyright ©2020
Copyright owner IMD Copyright
Organization Novartis
Industry Healthcare, Pharmaceuticals
Available Languages English
Contact

Research Information & Knowledge Hub for additional information on IMD publications